2882 (2882) Fair Value & Analysis

Consumer Cyclical · Market cap HK$102M

2 2882 2882 · HK

PriceHK$0.3800

Fair ValueHK$0.3559

Upside-6.3%

Quality41/100

Watch 2882 for free — get notified when fair value or trend changes. Watch for free

Evidence: Medium Range HK$0.3123 – HK$0.3559

Fair value as of: Jul 2, 2026

From 8 valuation models · updated today

Share price −17.4% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.3800 – HK$1.02 · fair‑value band HK$0.3123 – HK$0.3559 · the HK$0.3800 price screens above the HK$0.3559 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

2882 (2882) currently trades at HK$0.3800, while our model-based Fair Value estimate is HK$0.3559 — implying the stock looks roughly 6.3% overvalued today. We read business quality at 41/100 (below-average quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

Over the trailing twelve months, 2882 generated revenue of HK$1.4B at a net margin of -11.0%. Revenue grew 103.7% year over year. Net debt stands at HK$3.2B. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$1.4B

Revenue growth (YoY) +104%

Net margin -11.0%

Free cash flow −HK$413M FY2025

Operating margin 16.4%

EPS (TTM) HK$-0.3300

More key figures

Net debt HK$3.2B FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

2882 reported revenue of HK$1.4B in FY2026 versus HK$902M in FY2022, a compound +11.3%/yr. Reported net income was −HK$152M in FY2026.

Revenue +11.3%/yr

FY22 HK$902M

FY23 HK$619M

FY24 HK$605M

FY25 HK$949M

FY26 HK$1.4B

Net income

FY22 −HK$78.9M

FY23 −HK$89.7M

FY24 −HK$135M

FY25 −HK$126M

FY26 −HK$152M

Is 2882 fairly valued? → Check now

Similar stocks

6 more Luxury Goods stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
LVMH Moët Hennessy - Louis Vuitton, Société Européenne, LVMUY	$117.17	$80.70	-31%
Hermès International Société en commandite par actions HESAY	$202.49	$92.81	-54%
Compagnie Financière Richemont SA CFRHF	$221.58	$164.77	-26%
Christian Dior SE CHDRY	$127.13	$150.70	+19%
Titan Company TITAN	₹4,260	₹1,546	-64%
Kering SA PPRUF	$318.73	$86.83	-73%

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 2882 (2882) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$0.3559 versus a price of HK$0.3800 — about −6% (overvalued). Model-based estimate, not financial advice.

What is the fair value of 2882?

Our model-based fair value for 2882 is HK$0.3559 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.3800.

What is the quality score of 2882?

2882 has a Quality Score of 41/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 2882 (2882)?

2882 reported trailing-twelve-month revenue of about HK$1.4B (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 2882?

The net profit margin of 2882 is about -11.0%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.